Skip to main content

Table 1 miR-675-5p expression and clinicopathological features in non-small cell lung cancer(NSCLC) patients

From: Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer

Variable

miR-675-5p expression

Cases

Low

High

P-value a

Age(years)b

    

<57

58

43 (74%)

15 (26%)

0.8998

≥57

22

16 (73%)

6 (27%)

 

Gender

    

Male

33

24 (73%)

9 (27%)

0.8750

Female

47

35 (74%)

12 (26%)

 

Smoking history (years)b

    

<10

36

24 (67%)

12 (33%)

0.2094

≥10

44

35 (80%)

9 (20%)

 

Pathological type

    

adenocarcinoma

38

30 (79%)

8 (21%)

0.3391

squamous carcinoma

42

29 (69%)

13 (71%)

 

Tumor differentiation

    

I + II

46

37 (80%)

9 (20%)

0.0787

III + IV

34

22 (65%)

12 (35%)

 

TNM Classification

    

I

35

19 (54%)

16 (46%)

<0.005

II

27

24 (89%)

3 (11%)

III + IV

18

16 (89%)

2 (11%)

 

Metastasis

    

No

44

27 (61%)

17 (39%)

0.0055

Yes

36

32 (89%)

4 (11%)

 
  1. Abbreviations: TNM, tumor-node-metastasis; a×2test. bMean age.